Lv12
30 积分 2024-10-14 加入
Efficacy and safety of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in additional lumbar posterolateral fusion: minimum 1-year follow-up
2个月前
已完结
Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft
2个月前
已完结
皖公网安备34019202002308
